AAM
ABBV icon

American Asset Management’s AbbVie ABBV Stock Holding History

American Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,842
Closed -$871K – 10
2019
Q4 		$871K Sell
9,842
-384
-4% -$31.9K 0.56% 24
2019
Q3 		$774K Buy
10,226
+5,010
+96% +$343K 0.53% 25
2019
Q2 		$379K Buy
5,216
+950
+22% +$74.7K 0.26% 63
2019
Q1 		$344K Buy
4,266
+50
+1% +$4.09K 0.26% 60
2018
Q4 		$389K Sell
4,216
-100
-2% -$8.79K 0.29% 50
2018
Q3 		$408K Hold
4,316
– – 0.36% 56
2018
Q2 		$400K Hold
4,316
– – 0.26% 48
2018
Q1 		$409K Sell
4,316
-750
-15% -$82.4K 0.35% 45
2017
Q4 		$490K Sell
5,066
-200
-4% -$18.8K 0.3% 36
2017
Q3 		$468K Sell
5,266
-3,485
-40% -$265K 0.29% 34
2017
Q2 		$635K Buy
8,751
+82
+0.9% +$5.51K 0.36% 25
2017
Q1 		$565K Buy
8,669
+1,043
+14% +$65.6K 0.35% 27
2016
Q4 		$478K Buy
7,626
+1,628
+27% +$99.4K 0.53% 30
2016
Q3 		$378K Buy
+5,998
New +$388K 0.21% 34

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

American Asset Management's ABBV Position: Q1 2020 in Review

American Asset Management sold out of AbbVie (ABBV) in Q1 2020, closing a stake of 9,842 shares — an estimated $871K sold.

American Asset Management first reported a position in ABBV in Q3 2016 and held it in 14 quarters. The position peaked at $871K in Q4 2019. 2,225 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

  • American Asset Management reported no remaining AbbVie position as of Q1 2020 after selling out during the quarter.
  • American Asset Management sold 9,842 AbbVie shares in Q1 2020, an estimated $871K.
  • American Asset Management first reported a position in AbbVie in Q3 2016 and held it in 14 quarters.
  • American Asset Management's AbbVie position peaked at $871K in Q4 2019.
  • 2,225 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on American Asset Management's 13F filing for Q1 2020, filed 12 May 2020.